Clearstead Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $166K | Sell |
9,700
-1,087
| -10% | -$18.6K | ﹤0.01% | 924 |
|
|
2025
Q1 | $688K | Sell |
10,787
-992
| -8% | -$63.3K | 0.01% | 493 |
|
|
2024
Q4 | $1.43M | Hold |
11,779
| – | – | 0.02% | 347 |
|
|
2024
Q3 | $1.47M | Buy |
11,779
+3,147
| +36% | +$393K | 0.02% | 347 |
|
|
2024
Q2 | $1.36M | Buy |
8,632
+7,697
| +823% | +$1.22M | 0.02% | 337 |
|
|
2024
Q1 | $123K | Hold |
935
| – | – | 0.01% | 561 |
|
|
2023
Q4 | $90.2K | Sell |
935
-1,829
| -66% | -$176K | ﹤0.01% | 607 |
|
|
2023
Q3 | $335K | Buy |
2,764
+1,448
| +110% | +$176K | 0.01% | 463 |
|
|
2023
Q2 | $151K | Buy |
1,316
+961
| +271% | +$110K | 0.01% | 482 |
|
|
2023
Q1 | $48.9K | Buy |
+355
| New | +$48.9K | ﹤0.01% | 668 |
|
|
2022
Q4 | – | Sell |
-8
| Closed | -$1K | – | 1371 |
|
|
2022
Q3 | $1K | Hold |
8
| – | – | ﹤0.01% | 1194 |
|
|
2022
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 1221 |
|
|
2022
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 1321 |
|
|
2021
Q4 | $1K | Sell |
8
-252
| -97% | -$31.5K | ﹤0.01% | 1211 |
|
|
2021
Q3 | $24K | Buy |
260
+252
| +3,150% | +$23.3K | ﹤0.01% | 755 |
|
|
2021
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 1195 |
|
|
2021
Q1 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 1068 |
|